FRMD8 Targets Both CDK4 Activation and RB Degradation to Suppress Colon Cancer Growth

Investigators reported that FERM domain-containing 8 (FRMD8) inhibited cyclin-dependent kinase 4 (CDK4) activation and stabilized retinoblastoma protein, thereby causing cell-cycle arrest and inhibiting colorectal cancer cell growth.